A Bold Strategic Pivot with Honeywell Deal
Johnson Matthey’s £1.8bn sale of its Catalyst Technologies (CT) business to Honeywell isn’t just a transaction – it’s a full-scale corporate reinvention. Let’s unpack why this deal matters, what it means for shareholders, and how JM plans to rewrite its playbook.
The Numbers That Turn Heads
- Enterprise Value: £1.8bn (13.3x EBITDA – nearly double JM’s current group multiple)
- Shareholder Cash Return: £1.4bn (~£8/share) via yet-to-be-specified mechanisms
- Post-Sale Focus: Clean Air and PGMS divisions carrying the torch
Why Honeywell Bit So Hard
CT’s 150+ sustainable tech projects in the pipeline essentially sold themselves. With Honeywell hungry for net-zero solutions, JM’s catalysis IP became the golden goose. The 13.3x multiple suggests Honeywell sees CT’s EBITDA potentially doubling by 2030 – a bet on hydrogen and sustainable chemicals going mainstream.
Boardroom Calculus
Chair Patrick Thomas didn’t mince words: “This isn’t pruning – it’s uprooting the orchard to plant higher-yield crops.” The move follows 2024’s Medical Devices divestment, completing JM’s transformation from conglomerate to pure-play emissions tech specialist.
The New JM Blueprint
Post-sale, JM becomes a leaner beast targeting:
- Mid-single digit operating profit CAGR through 2028
- £250m+ annual free cash flow by 2028 (from current £180m)
- Dividend + buyback combo rising to £200m/year
“We’re not just shedding weight – we’re building Olympic-level sprinting capability,” CEO Liam Condon told analysts. The PGMS division’s platinum group metals expertise now takes centre stage, leveraging 200 years of institutional knowledge.
Shareholder Windfall – With Caveats
That £8/share return sounds juicy, but savvy investors should note:
- 88% of proceeds being returned leaves minimal war chest for M&A
- Regulatory approvals could push completion to H1 2026
- Warranty & indemnity insurance capped at £1 – a boardroom confidence play
The Execution Tightrope
JM’s success now hinges on:
- Clean Air maintaining 60%+ market share against BASF/UMICORE rivals
- PGMS monetising circular economy trends in platinum recycling
- Delivering promised £50m+ working capital improvements
Risks They’re Downplaying
The RNS mentions “streamlined operations”, but employee retention during this transition could prove tricky. With 1,900 CT staff moving to Honeywell, cultural spillover effects on remaining teams deserve monitoring.
My Take: High-Reward, Medium-Risk Gambit
This isn’t your typical “sell to survive” move. JM’s leadership is making an aggressive bet that focus + specialisation can drive premium valuations. If they hit those 2028 cash flow targets, today’s 5.7x EV/EBITDA multiple could expand towards Honeywell’s 13x – creating a potential double play for patient investors.
But make no mistake – this strips JM down to its technological core. The safety net’s gone. Every operational hiccup now carries magnified consequences. For a 209-year-old company, this might be its most daring chapter yet.
